Buprenorphine 2.0: I have my waiver, now what? Dr. Ritu Bhatnagar, M.D., M.P.H. Dr. John Ewing, M.D., FASAM. Disclosures

Similar documents
Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

Buprenorphine as a Treatment Option for Opioid Use Disorder

Medication-Assisted Treatment. What Is It and Why Do We Use It?

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

2/7/2017. Avoid compassion traps. Avoid All or Nothing Traps. Some Explanatory Models of Addiction

Principles and language suggestions for talking with patients

Rationale & Strategy For Integrating Buprenorphine Treatment Into Community Health Centers

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

John Murphy DO, MS Lynx Healthcare

Talking with your doctor

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

Agenda. Case Discussions. Managing Acute & Chronic Pain (requiring opioid analgesics) in Patients on MAT. Daniel Alford, MD Disclosures

OPIOIDS. Questions about opioids, and the Answers that may SURPRISE YOU. A booklet for people who may benefit from reducing or stopping their opioid

OPIOIDS. Questions about opioids, and the Answers that may SURPRISE YOU. A booklet for people who may benefit from reducing or stopping their opioid

The Social Worker s Role in Medication Assisted Treatment

Controlled Substance and Wellness Agreement

Medication-Assisted Treatment (MAT) Overview

Recognizing Narcotic Abuse and Addiction and Helping Those With It

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment

Medication-Assisted Treatment (MAT) for Opioid Use Disorders

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

Medication Assisted Treatment

Striking a Balance: a provider perspective.

Screening, Identification, Counseling, and Treatment of Opioid Use Disorder

About Your Pain Management

The CARA & Buprenorphine Prescribing for APNs & PAs

NURSING FOLLOW-UP: BUPRENORPHINE/NALOXONE BUPRENORPHINE/NALOXONE CLINIC VISITS

About Your Pain Management

Medication Assisted Treatment. Nicole Gastala, MD

OBSERVATION SHEET TOPIC CLINICAL SCENARIO. OBSERVATIONS MADE (Use the skills objectives/ provider tasks to evaluate the conversation)

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

Chronic Pain Pharmacist role in the clinic

Opioid Use Disorder Treatment: Buprenorphine Treatment Basics

Building capacity for a CHC response to Ontario's Opioid Crisis

Patient and Family Agreement on Opioids

7/7/2016 Journal of the American Medical Association,

Today the overuse of opioids is a problem. Many of

The science of the mind: investigating mental health Treating addiction

OPIOID PRESCRIBING RULES. May 17, 2017 Webinar

SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets. Risk Evaluation and Mitigation Strategy (REMS) Program

OUD & MAR: Caring for Our Communities

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Treatment of Substance Use Disorders in the Real World. Jessica M. Peirce, Ph.D. Johns Hopkins University School of Medicine

WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES?

The Challenging Patient with Chronic Opioid Usage MD ACP Meeting

Universal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Steven Prakken MD Director Medical Pain Service Duke Pain Medicine

History of Present Illness (HPI) Assessment and Plan Template

Taking Opioids Responsibly for Your Safety and the Safety of Others: Patient Information Guide on Long-term Opioid Therapy for Chronic Pain

Latest Press Release. How much for 30 mg adderall

Clinical Guidelines for the Pharmacologic Treatment of Opioid Use Disorder

Treating Opioid Addiction

Pain CONCERN. Medicines for long-term pain. Opioids

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

NALTREXONE DAVID CRABTREE, MD, MPH UNIVERSITY OF UTAH HEALTH, 2018

Opioid dependence and buprenorphine treatment

Prescription Drug Safety for Teens

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Methadone Maintenance 101

MEDICATION ASSISTED TREATMENT

FACING ADDICTION OVER DINNER

Traumatic Brain Injury and Sleep

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

Medication Agreements Promoting awareness, dialogue and level-set expectations

New Guidelines for Opioid Prescribing

IntNSA Webinar Series

PATIENT INTAKE: MEDICAL HISTORY. Name. Address. Phone (W) (H) (C) DOB Age SS# Emergency Contact. Relationship to patient Phone

STARTING SUBOXONE IN PRIMARY CARE

Patient Information Form

Basics of Benzodiazepine Use Disorder. DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR

Earl Hightower's Remarks 2014 National Rx Drug Abuse Summit Medication Assisted Treatment for Opiate Addiction

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

OPIOID PAIN MEDICATION Agreement and Informed Consent

Treatment Approaches for Drug Addiction

MAT for Opioid Dependence. MAT and Pain Management. Epidemiology. Epidemiology. Factors Impacting Pain Perception 9/23/2014

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

THE UNSTABLE BUPRENORPHINE- NALOXONE PATIENT

Acupuncture. Opioid Prescribing: Pitfalls for Occupational Medicine Physicians

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC

Understanding Medication in Addiction Treatment for Drug Court Participants

Treatment of Pain in an Emergent Setting

Jennifer Wyman, MD, Academic Lead, Opioids Clinical Primer Assistant Professor, Dept. of Family & Community Medicine, University of Toronto

Resist the Opioid Pendulum: Understanding Opioids and Pain, and how they relate to Addiction

Patient information sheet: BuTrans Patch This information should be read in conjunction with the Taking Opioids for pain information leaflet

What happens if you stop taking klonopin cold turkey

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

The Chronic Disease of Addiction Evidence and Lessons from Practice

National Council on Patient Information and Education

The Difficult Patient: Risk Mitigation Strategies

Opioids: Safe Use and Side Effects

Opioid Prescribing for Acute Pain

Medication Assisted Treatment in an Ideal Micro-Practice. Case: Typical Opioid Dependent Patient. John Machata, MD Wickford Family Medicine

Transcription:

Buprenorphine 2.0: I have my waiver, now what? Dr. Ritu Bhatnagar, M.D., M.P.H. Dr. John Ewing, M.D., FASAM Disclosures Dr. Bhatnagar: no disclosures to report Dr. Ewing: no disclosures to report 1

Our history with OUD Harm reduction, in brief: HONESTY, NOT PERFECTION 2

Patient selection: most responsive to OBOT: People in 20s or older Have an addiction to prescription opioids, but people with heroin use are treatable also Want to stop Stable support system at home Employed Stable on buprenorphine, transferred from more intensive addiction treatment program, with coordination from that program Case: Bob 30 y.o. single man with chronic back pain, lives with his parents. Was already on prescription oxycodone for a few years before transferring to your practice. Increasing pattern of running out early in the past 3 months, and unexpected opioids in his drug screen. You diagnose OUD, discuss starting buprenorphine/naloxone Bob agrees, shows up in withdrawal, does induction and stabilizes on 12 mg of buprenorphine/naloxone. You plan to see him back in 1 week. 3

A call from Bob He calls Thursday afternoon says: I ran out early, I m still in pain, and I am not sleeping well! What do you do? Bob s story Was taking 4 mg film three times a day With breakfast, lunch and dinner 4

Absorption technique: buccal vs. sublingual Pharmacokinetics: Circadian rhythm considerations Delay between starting buprenorphine and noticing pain relief Can expect to see gradual improvement in pain relief over the next 2 months Can use adjunctive modalities and reassurance during this time Divide total dose and take 3 4 times per day for chronic pain Case 2: Cindy 39 y.o. woman, living at home with significant other who doesn t use any illicit substances, is supportive. Medical history significant for type I DM, on insulin, stable. Has been maintained on buprenorphine/naloxone for 1 year on 8 mg sublingual dose per day, had prior Rx opioid misuse with subsequent heroin use. Is currently stable, employed, and has Medicaid insurance. You ve been seeing her monthly, at last visit found out she got a job promotion. 5

Cindy s woes Calls on Wednesday afternoon that she has run out early by 3 days. What do you do? Recall HONESTY, NOT PERFECTION 6

Cindy s response Has diabetic neuropathy. With new job promotion, had increased stress and physical demands. Neuropathy became severely painful, she was not sure what else to do. Had taken a few half strips extra over the past week. Please help me out, I don t want to lose my job! What do you do? OBOT guidelines: Follow up Assess stability: Ongoing use of illicit substances Taking medications as prescribed, side effects Changes in social function work, relationships Changes in medical health/ consequences of use Counseling/ community support group participation If stable, use positive reinforcement: Allow more time between visits every 2 weeks, then monthly. Prescribe larger quantities of medication as people demonstrate stability http://www.fsmb.org/globalassets/advocacy/policies/model policy on data 2000 and treatment of opioidaddiction in the medical office.pdf 7

Cindy in 2 months Has stabilized, taking divided doses as you suggested. Is grateful to have been understood and not cut off, agreed that coming in more often and having fewer strips available at a time was helpful for staying on track with counts. Started and found good relief of neuropathy from duloxetine. Is still stressed about new job. Can I get a dose increase of my Suboxone? I notice it s not lasting as long as it used to. What do you do? Role of therapy Counseling is a good adjunct, and often helpful Not necessary, and if person refuses, medication should not be withheld. However, medication can be used to leverage participation in counseling if there is need Counseling can help modulate stress response 8

Cindy Cindy tries counseling, learns some stress management techniques. After a few weeks, she is still noticing withdrawal symptoms later in the day. Now, what can you do? Tom: wants to start on MAT 35 y.o. Man, generally healthy, with daily heroin use, seeks your care. Is already taking lorazepam, 1 mg bid, for anxiety, prescribed by his PCP. He feels it is working well, has been on it for years. Hasn t tried much else for treatment. How do you proceed? 9

Common concerns: benzodiazepines Avoid concomitant prescriptions of opioids and benzodiazepines for risk of respiratory suppression. FDA in 9/2017: DON T withhold MAT from people taking benzodiazepines, but DO try other strategies for managing anxiety What is more deadly: heroin and benzodiazepines or buprenorphine and benzodiazepines? Enlist help of family member or use shorter prescriptions to avoid misuse. For Tom, suggest taper of lorazepam and try other anxiety medications as/ or before starting buprenorphine. Tom Tom, 35 y.o. man, now stable on 12 mg of buprenorphine/naloxone. Has been tapered off lorazepam successfully, and is doing well with sertraline and tizanidine as needed. He has done well with recovery, now stable for 1 year. Has dental procedure upcoming, horrible fear of dentist. Asks for something to help with anxiety. What do you do? 10

Mindy Mindy is a 48 y.o. Woman stable on 16 mg of buprenorphine/ naloxone for 1.5 years. Has done well with treatment, and has chronic arthritis. Her knee pain becomes worse in the winter, she slips and falls. Goes to the ER, tells them she is on buprenorphine. They call for assistance with pain management. What do you tell them? Common concerns: Acute Pain Management Usually continue buprenorphine through procedure Divide into more frequent doses (3 4 times per day vs. daily) Remember adjunctive pain measures: muscle relaxer, NSAID, ice, etc. If not sufficient, can use full agonist opioids plus buprenorphine but will often need 150 200% usual doses If hospitalized, or severe pain, can use fentanyl in monitored setting Ensure anxiety and depression, if present, are adequately treated Signals can often get confused 11

Mindy s surgery It is determined that she needs surgery to repair her broken leg. Surgeon and anesthesiologist call for direction about the buprenorphine/naloxone for the procedure. How do you advise Mindy and them? Anderson T et al. To Stop or Not, That is the Question. Anesthesiology 2017; 126:1180 6. 12

Anderson T et al. To Stop or Not, That is the Question. Anesthesiology 2017; 126:1180 6. Common concerns: Peri operative care Elective surgery: if anesthesia and major surgery, can stop buprenorphine before the procedure. If mild to moderate pain procedure, continue right through procedure (including delivery). Typical opioid doses for post operative pain will need to be 150 200% higher to account for tolerance. Prescribe these for as long as you would for someone who wasn t opioid dependent. Enlist help of family member or use shorter prescriptions to avoid misuse. 13

Peri operative management of buprenorphine patients Buprenorphine maintenance and muopioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy Mark K. Greenwalda,*, Sandra D. Comerb, and David A. Fiellin Drug Alcohol Depend. 2014 November 1; 0: 1 11. Case: Jack Jack is a 35 y.o. man who lives alone. Was using heroin, up to 1 g per day up to 3 months ago, when he started buprenorphine/naloxone with you. Otherwise healthy, no co morbidities Has been coming in every 2 weeks for buprenorphine/naloxone medication management, has stabilized on 16 mg sublingual dose per day. Last urine drug screen was positive for buprenorphine, on confirmation showed levels of 230 ng/ml, norbuprenorphine of 2000 ng/ml. 14

Urine Drug Screens: the basics.. And beyond Point of care is a SCREENING tool Adulterants as monitor for honesty Low temperature (falsified urine) Low creatinine (dilution) Abnormal ph Many false positives Can request buprenorphine metabolite levels once at a stable dose Opioid and benzodiazepine metabolism https://arupconsult.com/content/pain-and-addictionmanagement 15

16

Helen 35 y.o. Woman, married, with 3 young children, h/o prescription opioid dependence for really bad migraine headaches. Now stable on 4 mg Suboxone daily for 6 months. On asking, you discover she has been drinking quite regularly with her husband to unwind, celebrate, and perhaps more often... What do you do? Alcohol biomarkers Help quantify the amounts over the last 72 80 hours NOT a CLIA waived dipstick test, so can t always use this. These helped Helen be honest about the extent of her use. Counselor then discussed ways to cut down/ stop entirely. 17

Helen s challenge Harder to stop drinking alcohol than she realized Eventually realized anxiety was driving some of her drinking. Accepted sertraline for anxiety treatment. Also did well with topiramate to help reduce her cravings for alcohol, and helped her headaches, without weight gain. Are things going ok? Pattern of early refills Stolen/ lost medications Presence of other substances in urine drug screen Adulterated urine Drug screen confirmation: High buprenorphine, low (or absent) norbuprenorphine Diversion risk 18

What to do when Illicit substance use continues? Contingency Management processes for minor problems Invite person in for more frequent visits to discuss barriers to recovery Institute random pill/ film counts Random urine drug screens Reduced frequency of refills Can reduce dose Provide comfort medications Pt to file police report for stolen meds 19

Recognizing signs of IV drug use Track marks Hand, foot, leg, neck Long sleeves on hot days Do good physical exam Look for soft tissue/ skin infections When to refer Person is continuing to use other illicit substances Psychiatric co morbidity is interfering with treatment manage or refer to psychiatrist/ counselor Good to decide internal clinic rules for variability in progress: if presented early in treatment agreement, then not a surprise to person Consider harm reduction as part of the road to full recovery 20

21